First eye drop to improve public health gets green light in the United States

By: Trademagazin Date: 2025. 12. 28. 10:42

🎧 Hallgasd a cikket: Nyelv: Sebesség: 1.05×

The United States Food and Drug Administration (FDA) has approved VIZZ, a vision-improving eye drop containing aceclidine, which can improve near vision for up to 10 hours. The product is primarily intended for users affected by age-related vision loss (presbyopia) and is effective when applied once a day.

The eye drop works by slightly constricting the pupil, using the so-called “pinhole effect.” This allows close objects to be focused more sharply without impairing distance vision. A key element of the development is that it does not significantly stimulate the focusing muscles of the eye lens, thus avoiding the side effects – such as a feeling of pressure or visual distortion – that have limited previous similar solutions, writes Economyx.

During clinical trials, the product was used tens of thousands of times without serious side effects. The manufacturer expects the product to be commercially available in the United States in the fourth quarter of 2025.

From a market perspective, the launch of VIZZ could offer a new alternative for consumers using reading glasses and could have a noticeable impact on the optical device market, especially among the over-40s. Experts say that the rise of prescription vision correction could reshape the current practice of treating presbyopia in the medium term, while opening up a new growth path for ophthalmic innovations.